IMMUNOGENICITY AND SAFETY OF THE CHADOX 1 COVID-19 VACCINE IN PATIENTS WITH AUTOIMMUNE DISEASES AND HEALTHY CONTROLS: DATA FROM SAFER STUDY
Machado, KLLL; Martins, OA; Neto, ER; Miyamoto, ST; Moulaz, IR; Grillo, LL; Pasti, LP; Moulin, ACS; Souza, BO; Fae, F; Vieira, GSS; Surlo, HF; Macabu, MD; Corona, HD; Lorencini, PZ; Athayde, P; Aguiar, LGR; Albertino, LF; De Lima, MD; Burian, APN; Cruz, V; Kakehasi, A; Gomes, C; Azevedo, VF; Melo, AK; De Rezende, RPV; Ribeiro, S; Vieira, RMR; Tuao, RC; Lirio, MBB; Santo, TDRE; Pretti, FZ; Batista, DCFA; Monticielo, O; De Souza, V; Pinheiro, M; Ferreira, G; Sato, E; Teixeira-Carvalho, A; Xavier, R; Pileggi, GS; Valim, V
ANNALS OF THE RHEUMATIC DISEASES, 2022; 81 (): 980
